Modern medical management of endometriosis (Q40894046)

24 September 2017

1 reference

title

Modern medical management of endometriosis (English)

1 reference

24 September 2017

1 reference

Kettel LM

1

1 reference

24 September 2017

Hummel WP

series ordinal

2

1 reference

24 September 2017

publication date

1 June 1997

1 reference

Obstetrics and Gynecology Clinics of North America

24 September 2017

published in

1 reference

24 September 2017

volume

24

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

361-373

1 reference

Hormone treatment of endometriosis: the estrogen threshold hypothesis

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Human endometrium and endometriotic tissue obtained simultaneously: a comparative histological study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

The relation of endometriosis to menstrual characteristics, smoking, and exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

The unsuspected pelvic factor in the infertility investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Comparison of different modalities of treatment for minimal and mild endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Gestrinone versus danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Evaluation of histological and ultrastructural aspects of endometrium during treatment with gestrinone in women with amenorrhea or spotting

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Clinical Studies with an Antigonadotropin-Danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

The use of stilbestrol for endometriosis; preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Effect of gestrinone in endometriosis tissue and endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

The use of newer progestins in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

The Treatment of Endometriosis by Inducing Pseudopregnancy with Ovarian Hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Current status of the hormonal treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Danazol has progestin-like actions on the human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Treatment of endometriosis with estrogen-progestin combination and progestogens alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Endometrial effects of long-term low-dose administration of RU486

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Laparoscopic control of danazol therapy on pelvic endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Leuprolide acetate and bone mineral density measured by quantitative digitized radiography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Impact of gestrinone on the course of asymptomatic endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970309-0

7 January 2021

10.1016/S0889-8545(05)70309-0

Identifiers

DOI

1 reference

24 September 2017

1 reference